Claritev Total Current Liabilities 2019-2025 | CTEV

Claritev total current liabilities from 2019 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Claritev Annual Total Current Liabilities
(Millions of US $)
2024 $214
2023 $167
2022 $176
2021 $142
2020 $112
2019 $86
2018 $0
Claritev Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $180
2024-12-31 $214
2024-09-30 $201
2024-06-30 $181
2024-03-31 $194
2023-12-31 $167
2023-09-30 $172
2023-06-30 $147
2023-03-31 $156
2022-12-31 $176
2022-09-30 $230
2022-06-30 $148
2022-03-31 $202
2021-12-31 $142
2021-09-30 $167
2021-06-30 $112
2021-03-31 $216
2020-12-31 $112
2020-09-30 $9
2020-06-30 $2
2020-03-31 $0
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.761B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.084B 57.36
Doximity (DOCS) United States $11.307B 52.35
Hims & Hers Health (HIMS) United States $10.719B 111.37
Tempus AI (TEM) United States $9.847B 0.00
IRhythm Technologies (IRTC) United States $4.340B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.717B 0.00
Privia Health (PRVA) United States $2.496B 170.58
Enovis (ENOV) United States $1.944B 10.84
Phreesia (PHR) United States $1.590B 0.00
10x Genomics (TXG) United States $1.576B 0.00
Schrodinger (SDGR) United States $1.542B 0.00
Azenta (AZTA) United States $1.532B 71.21
Clover Health Investments (CLOV) United States $1.486B 0.00
Omnicell (OMCL) United States $1.344B 23.71
Evolent Health (EVH) United States $1.313B 111.80
Fulgent Genetics (FLGT) United States $0.587B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.501B 0.00
Butterfly Network (BFLY) United States $0.448B 0.00
Talkspace (TALK) United States $0.442B 132.00
Outset Medical (OM) United States $0.344B 0.00
TruBridge (TBRG) United States $0.331B 735.33
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Zepp Health (ZEPP) Netherlands $0.150B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.101B 3.84
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.068B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00